Tag: Merck

Merck drops oncolytic virus therapy Cavatak (V937)

ADC评论 October 29, 2022

On October 27, Merck announced its third-quarter financial report, and its product pipeline no longer includes the oncolytic virus therapy Cavatak (V937) obtained from the

Latest: Merck to buy Seagen fails to agree on price

ADC评论 August 27, 2022

According to Bloomberg, citing people familiar with the matter, the two companies have so far failed to agree on a price in talks to acquire

Merck and Cerevance collaborate to explore new targets for Alzheimer’s disease

ADC评论 August 11, 2022

On August 10, Merck and Cerevance announced that they have reached a strategic cooperation agreement to use Cerevance’s proprietary NETSseq transcriptomic technology platform to discover

Latest Articles

azide peg linker click chemistry

Leveraging Azide PEG in Biopharmaceuticals: Uniting Azide Linkers and Click Chemistry

October 20, 2023

peg-tco

TCO-Functionalized PEG Derivatives: Versatile Tools for Bioconjugation

October 16, 2023

Tetrazine PEG

Tetrazine and Methyltetrazine: Structural Distinctions and Their Roles in Pharmaceutical Research

October 8, 2023

endo bcn, exo bcn, bcn peg

BCN Compounds in Pharmaceutical Research and Development

October 6, 2023

cydyes

An Overview of Cyanine Dyes: Types, Wavelengths, and Applications Across Industries

September 19, 2023

Protein Conjugation

Unveiling the Power of Protein Conjugation: The Biochemical Game Changer

May 26, 2023

Hot Articles

Leveraging Azide PEG in Biopharmaceuticals: Uniting Azide Linkers and Click Chemistry

October 20, 2023

TCO-Functionalized PEG Derivatives: Versatile Tools for Bioconjugation

October 16, 2023

Tetrazine and Methyltetrazine: Structural Distinctions and Their Roles in Pharmaceutical Research

October 8, 2023

BCN Compounds in Pharmaceutical Research and Development

October 6, 2023